The Dividend Note
Dividend notes: profit upgrades x3 - HILS, AZN, BME (14/11/23)
I take a look at AstraZeneca, B&M and Hill & Smith; all three companies have upgraded their profit guidance over the last week.
The Dividend Note
I take a look at AstraZeneca, B&M and Hill & Smith; all three companies have upgraded their profit guidance over the last week.
The Dividend Note
My thoughts on this week's market-moving trading updates from Diageo, Redrow and Taylor Wimpey.
The Dividend Note
Half-year results from Marks and Spencer and RS Group provide a sharp contrast in performance.
Portfolio
October's results from my portfolio companies didn't flag up any new problems. I think there's plenty of value in UK dividend shares right now.
The Dividend Note
I review third-quarter updates from FTSE 100 dividend shares BP, GSK and Next.
The Dividend Note
I review third-quarter updates from FTSE 250 precision engineer Spectris and financial firm TP ICAP, which has an 8% dividend yield.
The Dividend Note
I review recent results from UK dividend shares AG Barr, Mortgage Advice Bureau, and James Halstead.
The Dividend Note
I review the latest updates from Harry Potter publisher Bloomsbury Publishing and FTSE 250 automotive group Inchcape.
Podcasts
I've recorded several new podcasts over the last month, covering topics including Hargreaves Lansdown, Quartix, Focusrite, Strix - and the difficult topic of company valuation.
Portfolio
The third quarter saw me add two new stocks to my quality dividend portfolio, which remains on track to deliver a 5.5% yield this year.
Portfolio
External conditions are providing challenges for some of the companies in my dividend portfolio, but I'm reassured by most of these updates.
Newsletter
I'm maxing out my trading policy this month by buying a second new share for my model dividend portoflio.
Disclaimer: All content provided on this website is intended for educational and entertainment purposes only. This website does not provide investment advice or recommendations. You should research all investment decisions yourself and not rely upon information provided on this website. If you are unable to do this you should seek professional advice from a registered financial adviser.